SCHEMBL7066010

SCHEMBL7066010

Cc1ccc(S(=O)(=O)ON(N=Cc2ccc([N+](=O)[O-])cc2)C(=N)N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 2/20 0.41
GRIN3B O60391 2/20 0.41
GRIN1 Q05586 2/20 0.41
GRIN2A Q12879 2/20 0.41
GRIN2B Q13224 2/20 0.41
GRIN2C Q14957 2/20 0.41
GRIN3A Q8TCU5 2/20 0.41
ATM Q13315 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
PTGS2 P35354 1/20 0.41
CA9 Q16790 1/20 0.41
MAPT P10636 7/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 2/20 0.41
GAA P10253 1/20 0.41
ALDH1A1 P00352 3/20 0.40
CYP2C9 P11712 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL915169 0.88 ALDH1A1 (0.53) CA12CA1CA2PTGS2CA9
SCHEMBL7065198 0.86 ATM (0.45) ATMCA12CA1CA2PTGS2
SCHEMBL7066729 0.85 ALDH1A1 (0.53) MAPTMEN1KMT2ALMNAGAA
SCHEMBL7062256 0.84 ALDH1A1 (0.41) MAPTMEN1KMT2ALMNAGAA
SCHEMBL7062930 0.84 ALDH1A1 (0.39) CA12CA1CA2CA9MAPT
SCHEMBL7065975 0.83 MAPT (0.39) MAPTMEN1KMT2ALMNAALDH1A1
SCHEMBL7062491 0.83 ALDH1A1 (0.44) CA12CA1CA2CA9MAPT
SCHEMBL7065577 0.81 ALDH1A1 (0.37) MAPTMEN1KMT2ALMNAGAA
SCHEMBL7066006 0.80 GRIN2D (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7066007 0.80 GRIN2D (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1313461-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS Melacure Therapeutics AB (SE) 2003-05-28 EP claimed
WO-2002011715-A2 THE USE OF BENZYLIDENEAMINOGUANIDINES AND HYDROXYGUANIDINES AS MELANOCORTIN RECEPTOR LIGANDS MELACURE THERAPEUTICS AB (SE) 2002-02-14 WO claimed